US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alkermes PLC

40.11

-1.3350-3.22%

Pre-market: 40.310.2003+0.50%08:17 EDT

Volume:3.25M

Turnover:130.30M

Market Cap:6.73B

PE:103.31

High:41.26

Open:41.10

Low:39.11

Close:41.45

52wk High:55.67

52wk Low:27.00

Shares:167.76M

Float Shares:155.00M

Volume Ratio:1.41

T/O Rate:2.10%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.3882

EPS(LYR):1.43

ROE:3.85%

ROA:4.20%

PB:3.72

PE(LYR):28.05

Loading ...

Overview Company News Filings

Alkermes presents new phase 2 Vibrance-2 data for alixorexton in narcolepsy type 2 at SLEEP 2026

Mizuho Securities Reaffirms Their Buy Rating on Alkermes (ALKS)

Alkermes to join Goldman Sachs Global Healthcare Conference fireside chat

Is Alkermes’ (ALKS) New LYBALVI Real-World Data Quietly Reframing Its Psychiatry Investment Story?

Simply Wall St.

Alkermes Chief Medical Officer Craig Hopkinson sells 9,000 shares for $375,044‬

Alkermes VP Finance Samuel Joseph Parisi disposes of 16,217 shares for $686,807.86

Needham Reiterates Buy Rating on Alkermes as Preclinical ALKS 7290 Data Support Unchanged $50 Price Target

Alkermes presents Phase 2 Vibrance-1 data on alixorexton in narcolepsy type 1 at ASCP meeting

Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting

THOMSON REUTERS

Alkermes presents real-world study comparing Lybalvi versus olanzapine adherence, relapse proxies

Alkermes shareholders approve 2018 stock plan share increase by 5.9 million

Alkermes Advances Phase 3 Narcolepsy Study With ALKS 2680, Adding a New Catalyst to Its Pipeline

Alkermes Is Maintained at Outperform by Baird

Sector Update: Healthcare Stocks Advance Late Afternoon

MT Newswires Live

Alkermes' (NASDAQ:ALKS) Conservative Accounting Might Explain Soft Earnings

Simply Wall St.

Stock Track | Alkermes Soars 6.37% Intraday on Positive Phase 3 Trial Results for Lumryz in Idiopathic Hypersomnia

Alkermes Phase 3 Trial Meets Primary Endpoint for Hypersomnia Treatment

MT Newswires Live

Analysts Conflicted on These Healthcare Names: Cronos Group (CRON), Savara (SVRA) and Alkermes (ALKS)

BRIEF-Alkermes Announces Positive Topline Results From Revitalyz Phase 3 Study Evaluating Lumryz

Alkermes says Phase 3 REVITALYZ trial shows LUMRYZ improves idiopathic hypersomnia sleepiness

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/ALKS/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ALKS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALKS\",,,,,undefined,":{"symbol":"ALKS","market":"US","secType":"STK","nameCN":"Alkermes PLC","latestPrice":40.11,"timestamp":1791489600000,"preClose":41.445,"halted":0,"volume":3251030,"hourTrading":{"tag":"盘前","latestPrice":40.3103,"preClose":40.11,"latestTime":"08:17 EDT","volume":8,"amount":318.560304,"timestamp":1791548252869,"change":0.2003,"changeRate":0.004994,"amplitude":0.013969},"delay":0,"changeRate":-0.03221136445892148,"floatShares":155000000,"shares":167763272,"eps":0.388236,"marketStatus":"Pre-Mkt","change":-1.335,"latestTime":"10-09 08:37:06 EDT","open":41.1,"high":41.26,"low":39.105,"amount":130302550.30170001,"amplitude":0.051997,"askPrice":40.99,"askSize":65,"bidPrice":39.76,"bidSize":65,"shortable":3,"etf":0,"ttmEps":0.388236,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791552600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":40.11,"preHourTrading":{"tag":"盘前","latestPrice":40.3103,"preClose":40.11,"latestTime":"08:17 EDT","volume":8,"amount":318.560304,"timestamp":1791548252869,"change":0.2003,"changeRate":0.004994,"amplitude":0.013969},"postHourTrading":{"tag":"盘后","latestPrice":40.11,"preClose":40.11,"latestTime":"19:30 EDT","volume":66527,"amount":2668397.91,"timestamp":1791502204101,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.4089393276163236,"impliedVol":0.4597,"impliedVolPercentile":0.316},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALKS\",,,,,undefined,":{"symbol":"ALKS","floatShares":155000000,"roa":"4.20%","roe":"3.85%","lyrEps":1.43,"volumeRatio":1.4089393276163236,"shares":167763272,"dividePrice":0,"high":41.26,"amplitude":0.051997,"preClose":41.445,"low":39.105,"week52Low":27,"pbRate":"3.72","psRate":"4.04","week52High":55.67,"institutionHeld":0.9671,"latestPrice":40.11,"eps":0.388236,"divideRate":0,"volume":3251030,"delay":0,"ttmEps":0.388236,"open":41.1,"prevYearClose":27.98,"prevWeekClose":41.75,"prevMonthClose":40.52,"prevQuarterClose":40.52,"fiveDayClose":40.54,"twentyDayClose":46.11,"sixtyDayClose":51.98,"dividendPayoutRate":0,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALKS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-28","symbol":"ALKS","fiscalQuarterEnding":"2026/06","expectedEps":-0.04,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785211200000,"reportTimeType":"pre","actualEps":0},{"market":"US","date":"2026-05-05","symbol":"ALKS","fiscalQuarterEnding":"2026/03","expectedEps":-0.57,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2026-02-25","symbol":"ALKS","fiscalQuarterEnding":"2025/12","expectedEps":0.31,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"pre","actualEps":0.34},{"market":"US","date":"2026-01-12","symbol":"ALKS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-10-28","symbol":"ALKS","fiscalQuarterEnding":"2025/09","expectedEps":0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"pre","actualEps":0.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALKS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALKS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.5,"hold":0.25,"sell":0.05,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":20,"updateTime":1790308800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALKS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALKS","date":"2026-10-08","current":103.313449,"percent":0.964687,"low":-99.853332,"twenty":-39.176615,"median":13.65193,"eighty":20.12853,"high":128.125542,"avg":-0.516776,"sd":44.023426,"marketCap":6952948808},"quantilePoints":[{"date":"2021-10-15","current":-81.320536,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":5109369301},{"date":"2021-10-22","current":-79.214984,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4977077453},{"date":"2021-10-29","current":-53.423232,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4898055566},{"date":"2021-11-05","current":-53.493781,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4904523781},{"date":"2021-11-12","current":-42.294127,"twenty":-50.154251,"median":-35.906358,"eighty":-20.409777,"marketCap":3877694700},{"date":"2021-11-19","current":-40.98897,"twenty":-49.694628,"median":-35.906358,"eighty":-20.409777,"marketCap":3758032729},{"date":"2021-11-26","current":-39.630902,"twenty":-49.492729,"median":-35.906358,"eighty":-20.409777,"marketCap":3633519596},{"date":"2021-12-03","current":-38.8725,"twenty":-49.409499,"median":-35.906358,"eighty":-20.409777,"marketCap":3563986288},{"date":"2021-12-10","current":-38.502118,"twenty":-49.260842,"median":-35.906358,"eighty":-20.409777,"marketCap":3530028161},{"date":"2021-12-17","current":-41.200617,"twenty":-48.983435,"median":-35.906358,"eighty":-20.409777,"marketCap":3777437373},{"date":"2021-12-23","current":-42.488136,"twenty":-48.911898,"median":-35.906358,"eighty":-20.409777,"marketCap":3895482291},{"date":"2021-12-31","current":-41.024245,"twenty":-48.71686,"median":-35.906358,"eighty":-20.409777,"marketCap":3761266836},{"date":"2022-01-07","current":-42.347038,"twenty":-48.396814,"median":-35.934227,"eighty":-20.409786,"marketCap":3882545861},{"date":"2022-01-14","current":-44.534057,"twenty":-48.237657,"median":-35.934227,"eighty":-20.409786,"marketCap":4083060516},{"date":"2022-01-21","current":-42.329401,"twenty":-48.134628,"median":-35.934227,"eighty":-20.409786,"marketCap":3880928808},{"date":"2022-01-28","current":-44.234224,"twenty":-47.856145,"median":-35.934227,"eighty":-20.409786,"marketCap":4055570604},{"date":"2022-02-04","current":-41.817921,"twenty":-47.644696,"median":-35.934227,"eighty":-20.409786,"marketCap":3834034251},{"date":"2022-02-11","current":-40.918421,"twenty":-47.524593,"median":-35.934227,"eighty":-20.409786,"marketCap":3751564514},{"date":"2022-02-18","current":-84.332018,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4062188990},{"date":"2022-02-25","current":-83.424138,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4018457290},{"date":"2022-03-04","current":-77.943229,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":3754447400},{"date":"2022-03-11","current":-81.978254,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":3948810510},{"date":"2022-03-18","current":-87.82904,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4230637018},{"date":"2022-03-25","current":-92.233942,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4442816746},{"date":"2022-04-01","current":-94.35233,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4544857379},{"date":"2022-04-08","current":-99.631487,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4799149114},{"date":"2022-04-14","current":-98.723607,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4755417414},{"date":"2022-04-22","current":-95.615075,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4605682543},{"date":"2022-04-29","current":-76.473016,"twenty":-47.524593,"median":-36.079146,"eighty":-20.409786,"marketCap":4714867305},{"date":"2022-05-06","current":-73.239148,"twenty":-47.644696,"median":-36.311039,"eighty":-20.409786,"marketCap":4515486435},{"date":"2022-05-13","current":-71.251115,"twenty":-47.856145,"median":-36.514549,"eighty":-20.409786,"marketCap":4392916227},{"date":"2022-05-20","current":-79.521333,"twenty":-48.134628,"median":-36.669968,"eighty":-20.409786,"marketCap":4902808290},{"date":"2022-05-27","current":-80.952717,"twenty":-48.282786,"median":-36.809313,"eighty":-20.409786,"marketCap":4991058839},{"date":"2022-06-03","current":-77.692343,"twenty":-48.396814,"median":-36.895372,"eighty":-20.409786,"marketCap":4790043699},{"date":"2022-06-10","current":-73.104657,"twenty":-48.753891,"median":-37.077955,"eighty":-20.409786,"marketCap":4507194550},{"date":"2022-06-17","current":-74.622125,"twenty":-48.950091,"median":-37.212055,"eighty":-20.409786,"marketCap":4600752485},{"date":"2022-06-24","current":-79.09466,"twenty":-49.022902,"median":-37.321505,"eighty":-20.409777,"marketCap":4876502188},{"date":"2022-07-01","current":-81.277684,"twenty":-49.282838,"median":-37.389331,"eighty":-20.409777,"marketCap":5011094305},{"date":"2022-07-08","current":-84.791819,"twenty":-49.409499,"median":-37.46584,"eighty":-20.409777,"marketCap":5227754786},{"date":"2022-07-15","current":-79.68035,"twenty":-49.492729,"median":-37.601025,"eighty":-20.409777,"marketCap":4912612269},{"date":"2022-07-22","current":-76.725281,"twenty":-49.769136,"median":-37.711507,"eighty":-20.409777,"marketCap":4730420500},{"date":"2022-07-29","current":-44.659913,"twenty":-50.043112,"median":-37.815476,"eighty":-20.409777,"marketCap":4204909440},{"date":"2022-08-05","current":-44.956483,"twenty":-50.043112,"median":-37.914647,"eighty":-20.409777,"marketCap":4232832666},{"date":"2022-08-12","current":-45.619403,"twenty":-50.043112,"median":-38.002104,"eighty":-20.409777,"marketCap":4295249291},{"date":"2022-08-19","current":-44.066773,"twenty":-50.043112,"median":-38.10506,"eighty":-20.409777,"marketCap":4149062986},{"date":"2022-08-26","current":-42.810713,"twenty":-50.043112,"median":-38.291941,"eighty":-20.409777,"marketCap":4030799908},{"date":"2022-09-02","current":-42.758378,"twenty":-50.043112,"median":-38.448007,"eighty":-20.409777,"marketCap":4025872280},{"date":"2022-09-09","current":-41.886114,"twenty":-50.043112,"median":-38.5362,"eighty":-20.409777,"marketCap":3943745142},{"date":"2022-09-16","current":-40.769616,"twenty":-50.043112,"median":-38.660853,"eighty":-20.409777,"marketCap":3838622406},{"date":"2022-09-23","current":-38.937862,"twenty":-50.043112,"median":-38.765906,"eighty":-20.409777,"marketCap":3666155418},{"date":"2022-09-30","current":-38.955307,"twenty":-50.043112,"median":-38.937862,"eighty":-20.409777,"marketCap":3667797960},{"date":"2022-10-07","current":-38.606401,"twenty":-50.043112,"median":-39.109838,"eighty":-20.409777,"marketCap":3634947105},{"date":"2022-10-14","current":-39.46122,"twenty":-50.043112,"median":-39.133049,"eighty":-20.409777,"marketCap":3715431700},{"date":"2022-10-21","current":-38.83319,"twenty":-50.043112,"median":-39.135862,"eighty":-20.409777,"marketCap":3656300161},{"date":"2022-10-28","current":-40.699835,"twenty":-50.043112,"median":-39.199541,"eighty":-20.409777,"marketCap":3832052235},{"date":"2022-11-04","current":-30.511153,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3940210296},{"date":"2022-11-11","current":-30.014933,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3876128478},{"date":"2022-11-18","current":-29.824079,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3851481624},{"date":"2022-11-25","current":-30.791072,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3976359015},{"date":"2022-12-02","current":-33.195829,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4286909368},{"date":"2022-12-09","current":-31.427251,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4058515193},{"date":"2022-12-16","current":-32.470585,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4193251325},{"date":"2022-12-23","current":-32.432414,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4188321954},{"date":"2022-12-30","current":-33.246723,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4293481862},{"date":"2023-01-06","current":-34.493635,"twenty":-49.769136,"median":-39.154696,"eighty":-20.409777,"marketCap":4454507971},{"date":"2023-01-13","current":-34.748106,"twenty":-49.492729,"median":-39.12976,"eighty":-20.409777,"marketCap":4487370442},{"date":"2023-01-20","current":-35.269773,"twenty":-49.420616,"median":-39.023312,"eighty":-20.409777,"marketCap":4554738508},{"date":"2023-01-27","current":-36.923839,"twenty":-49.282838,"median":-38.850635,"eighty":-20.409777,"marketCap":4768344571},{"date":"2023-02-03","current":-34.799001,"twenty":-48.983435,"median":-38.742102,"eighty":-20.409777,"marketCap":4493942936},{"date":"2023-02-10","current":-34.468187,"twenty":-48.9133,"median":-38.606401,"eighty":-20.409777,"marketCap":4451221724},{"date":"2023-02-17","current":-29.155811,"twenty":-48.645431,"median":-38.5362,"eighty":-20.409777,"marketCap":4614402682},{"date":"2023-02-24","current":-28.231383,"twenty":-48.351507,"median":-38.448007,"eighty":-20.409777,"marketCap":4468096363},{"date":"2023-03-03","current":-28.304091,"twenty":-48.220837,"median":-38.373879,"eighty":-20.409777,"marketCap":4479603601},{"date":"2023-03-10","current":-27.639335,"twenty":-48.116754,"median":-38.274941,"eighty":-20.409777,"marketCap":4374394563},{"date":"2023-03-17","current":-27.036899,"twenty":-47.811464,"median":-38.093155,"eighty":-20.409777,"marketCap":4279048871},{"date":"2023-03-24","current":-27.514693,"twenty":-47.598057,"median":-37.993052,"eighty":-20.409777,"marketCap":4354667868},{"date":"2023-03-31","current":-29.280453,"twenty":-47.463781,"median":-37.913785,"eighty":-20.409786,"marketCap":4634129377},{"date":"2023-04-06","current":-30.506098,"twenty":-47.463781,"median":-37.82284,"eighty":-20.409786,"marketCap":4828108542},{"date":"2023-04-14","current":-31.035826,"twenty":-47.475869,"median":-37.711507,"eighty":-20.409777,"marketCap":4911946995},{"date":"2023-04-21","current":-30.121785,"twenty":-47.475869,"median":-37.601025,"eighty":-20.409777,"marketCap":4767284567},{"date":"2023-04-28","current":-28.670049,"twenty":-47.475869,"median":-37.46584,"eighty":-20.409777,"marketCap":4707880022},{"date":"2023-05-05","current":-29.044358,"twenty":-47.475869,"median":-37.38821,"eighty":-20.409777,"marketCap":4769344934},{"date":"2023-05-12","current":-31.543123,"twenty":-47.378573,"median":-37.313027,"eighty":-20.409777,"marketCap":5179664753},{"date":"2023-05-19","current":-30.531477,"twenty":-47.214893,"median":-37.152993,"eighty":-20.409777,"marketCap":5013543369},{"date":"2023-05-26","current":-29.722161,"twenty":-47.214893,"median":-36.987674,"eighty":-20.409777,"marketCap":4880646261},{"date":"2023-06-02","current":-29.620996,"twenty":-47.130816,"median":-36.919193,"eighty":-20.409767,"marketCap":4864034123},{"date":"2023-06-09","current":-31.907316,"twenty":-46.901522,"median":-36.809313,"eighty":-20.409767,"marketCap":5239468451},{"date":"2023-06-16","current":-32.301858,"twenty":-46.574329,"median":-36.669968,"eighty":-20.409767,"marketCap":5304255791},{"date":"2023-06-23","current":-34.021656,"twenty":-46.462045,"median":-36.564066,"eighty":-20.409758,"marketCap":5586662143},{"date":"2023-06-30","current":-31.69487,"twenty":-46.464564,"median":-36.443843,"eighty":-20.409749,"marketCap":5204582960},{"date":"2023-07-07","current":-30.399963,"twenty":-46.464564,"median":-36.324905,"eighty":-20.409749,"marketCap":4991947589},{"date":"2023-07-14","current":-30.359498,"twenty":-46.464564,"median":-36.212917,"eighty":-20.409749,"marketCap":4985302733},{"date":"2023-07-21","current":-32.342324,"twenty":-46.464564,"median":-35.934227,"eighty":-20.409749,"marketCap":5310900646},{"date":"2023-07-28","current":48.950981,"twenty":-46.442933,"median":-35.452039,"eighty":-20.368741,"marketCap":5041559440},{"date":"2023-08-04","current":44.683255,"twenty":-46.317214,"median":-35.211157,"eighty":-20.301088,"marketCap":4602017848},{"date":"2023-08-11","current":44.87732,"twenty":-45.967039,"median":-35.023652,"eighty":-20.120159,"marketCap":4622004896},{"date":"2023-08-18","current":46.446004,"twenty":-45.664437,"median":-34.69182,"eighty":-19.956848,"marketCap":4783566869},{"date":"2023-08-25","current":44.570051,"twenty":-45.404618,"median":-34.474549,"eighty":-19.830023,"marketCap":4590358736},{"date":"2023-09-01","current":47.206089,"twenty":-44.974989,"median":-34.130848,"eighty":-19.651548,"marketCap":4861849474},{"date":"2023-09-08","current":47.206089,"twenty":-44.907093,"median":-33.585511,"eighty":-19.51296,"marketCap":4861849474},{"date":"2023-09-15","current":48.273441,"twenty":-44.907093,"median":-33.253085,"eighty":-19.271435,"marketCap":4971778239},{"date":"2023-09-22","current":48.047033,"twenty":-44.802128,"median":-33.04036,"eighty":-19.191423,"marketCap":4948460016},{"date":"2023-09-29","current":45.540372,"twenty":-44.659913,"median":-32.766368,"eighty":-19.065691,"marketCap":4690293977},{"date":"2023-10-06","current":45.993188,"twenty":-44.528541,"median":-32.483308,"eighty":-18.951388,"marketCap":4736930423},{"date":"2023-10-13","current":44.262783,"twenty":-44.236515,"median":-32.381007,"eighty":-18.699922,"marketCap":4558712576},{"date":"2023-10-20","current":43.357151,"twenty":-44.110763,"median":-32.257067,"eighty":-18.558361,"marketCap":4465439685},{"date":"2023-10-27","current":19.196586,"twenty":-44.052817,"median":-32.165219,"eighty":-18.485448,"marketCap":4121967764},{"date":"2023-11-03","current":19.080008,"twenty":-43.835622,"median":-32.114324,"eighty":-18.329394,"marketCap":4096935571},{"date":"2023-11-10","current":19.04892,"twenty":-43.835622,"median":-31.907316,"eighty":-18.128571,"marketCap":4090260319},{"date":"2023-11-17","current":18.162924,"twenty":-43.835622,"median":-31.735336,"eighty":-17.870084,"marketCap":3900015653},{"date":"2023-11-24","current":18.955657,"twenty":-43.835622,"median":-31.583589,"eighty":-17.644018,"marketCap":4070234565},{"date":"2023-12-01","current":18.76136,"twenty":-43.835622,"median":-31.427251,"eighty":-17.293018,"marketCap":4028514244},{"date":"2023-12-08","current":20.331283,"twenty":-43.821513,"median":-31.320561,"eighty":-17.111515,"marketCap":4365614441},{"date":"2023-12-15","current":20.945263,"twenty":-43.821513,"median":-30.985981,"eighty":-16.974211,"marketCap":4497450657},{"date":"2023-12-22","current":21.411577,"twenty":-43.821513,"median":-30.840029,"eighty":-16.775651,"marketCap":4597579429},{"date":"2023-12-29","current":21.668049,"twenty":-43.835622,"median":-30.75404,"eighty":-16.674022,"marketCap":4652650253},{"date":"2024-01-05","current":22.250942,"twenty":-43.849732,"median":-30.587118,"eighty":-16.545483,"marketCap":4777811218},{"date":"2024-01-12","current":21.714681,"twenty":-43.849732,"median":-30.537472,"eighty":-16.468673,"marketCap":4662663130},{"date":"2024-01-19","current":21.574787,"twenty":-43.863842,"median":-30.498429,"eighty":-16.419138,"marketCap":4632624499},{"date":"2024-01-26","current":21.776856,"twenty":-43.849732,"median":-30.390709,"eighty":-16.359531,"marketCap":4676013633},{"date":"2024-02-02","current":20.937491,"twenty":-43.849732,"median":-30.268366,"eighty":-16.245798,"marketCap":4495781844},{"date":"2024-02-09","current":20.805369,"twenty":-43.849732,"median":-30.124302,"eighty":-16.099824,"marketCap":4467412026},{"date":"2024-02-16","current":15.282535,"twenty":-43.849732,"median":-30.000061,"eighty":-15.989003,"marketCap":5436868800},{"date":"2024-02-23","current":13.569352,"twenty":-43.849732,"median":-29.813586,"eighty":-15.868185,"marketCap":4827391800},{"date":"2024-03-01","current":13.943479,"twenty":-43.835622,"median":-29.691811,"eighty":-15.810302,"marketCap":4960490388},{"date":"2024-03-08","current":13.830767,"twenty":-43.835622,"median":-29.445673,"eighty":-15.761184,"marketCap":4920392116},{"date":"2024-03-15","current":13.563075,"twenty":-43.835622,"median":-29.155811,"eighty":-15.689068,"marketCap":4825158721},{"date":"2024-03-22","current":12.666071,"twenty":-43.835622,"median":-28.997047,"eighty":-15.65825,"marketCap":4506043307},{"date":"2024-03-28","current":12.797569,"twenty":-43.835622,"median":-28.957305,"eighty":-15.60417,"marketCap":4552824624},{"date":"2024-04-05","current":12.121293,"twenty":-43.849732,"median":-28.827848,"eighty":-15.449766,"marketCap":4312234992},{"date":"2024-04-12","current":11.884271,"twenty":-43.849732,"median":-28.713822,"eighty":-15.310254,"marketCap":4227912733},{"date":"2024-04-19","current":11.299331,"twenty":-43.849732,"median":-28.508069,"eighty":-15.24785,"marketCap":4019816188},{"date":"2024-04-26","current":11.622713,"twenty":-43.835622,"median":-28.43912,"eighty":-15.200526,"marketCap":4134861432},{"date":"2024-05-03","current":9.294065,"twenty":-43.835622,"median":-28.43912,"eighty":-15.01869,"marketCap":4037620480},{"date":"2024-05-10","current":9.449875,"twenty":-43.835622,"median":-28.43912,"eighty":-14.970096,"marketCap":4105309004},{"date":"2024-05-17","current":9.52778,"twenty":-43.835622,"median":-28.43912,"eighty":-14.582911,"marketCap":4139153267},{"date":"2024-05-24","current":9.348598,"twenty":-43.835622,"median":-28.43912,"eighty":-14.167324,"marketCap":4061311464},{"date":"2024-05-31","current":9.114883,"twenty":-43.835622,"median":-28.43912,"eighty":-13.940216,"marketCap":3959778677},{"date":"2024-06-07","current":9.313541,"twenty":-43.835622,"median":-28.43912,"eighty":-13.607896,"marketCap":4046081546},{"date":"2024-06-14","current":9.543361,"twenty":-43.835622,"median":-28.43912,"eighty":-13.123801,"marketCap":4145922119},{"date":"2024-06-21","current":9.718647,"twenty":-43.849732,"median":-28.439666,"eighty":-12.956146,"marketCap":4222071709},{"date":"2024-06-28","current":9.387551,"twenty":-43.849732,"median":-28.439666,"eighty":-12.533786,"marketCap":4078233595},{"date":"2024-07-05","current":9.46156,"twenty":-43.849732,"median":-28.439666,"eighty":-12.248451,"marketCap":4110385644},{"date":"2024-07-12","current":9.181102,"twenty":-43.849732,"median":-28.439666,"eighty":-11.555991,"marketCap":3988546300},{"date":"2024-07-19","current":9.671904,"twenty":-43.849732,"median":-28.439666,"eighty":-11.295982,"marketCap":4201765152},{"date":"2024-07-26","current":15.900891,"twenty":-43.849732,"median":-28.439666,"eighty":-10.747072,"marketCap":4590953012},{"date":"2024-08-02","current":15.809638,"twenty":-43.849732,"median":-28.439666,"eighty":9.065803,"marketCap":4564606079},{"date":"2024-08-09","current":14.868588,"twenty":-43.849732,"median":-28.439666,"eighty":9.206032,"marketCap":4292903337},{"date":"2024-08-16","current":15.541581,"twenty":-43.849732,"median":-28.439666,"eighty":9.350072,"marketCap":4487211965},{"date":"2024-08-23","current":15.940815,"twenty":-43.849732,"median":-28.439666,"eighty":9.384045,"marketCap":4602479795},{"date":"2024-08-30","current":16.225981,"twenty":-43.849732,"median":-28.439666,"eighty":9.410143,"marketCap":4684813960},{"date":"2024-09-06","current":15.319151,"twenty":-43.849732,"median":-28.439666,"eighty":9.422608,"marketCap":4422991316},{"date":"2024-09-13","current":15.775418,"twenty":-43.849732,"median":-28.439666,"eighty":9.46156,"marketCap":4554725980},{"date":"2024-09-20","current":16.283014,"twenty":-43.849732,"median":-28.439666,"eighty":9.509862,"marketCap":4701280792},{"date":"2024-09-27","current":15.701275,"twenty":-43.849732,"median":-28.439666,"eighty":9.56787,"marketCap":4533319097},{"date":"2024-10-04","current":16.522554,"twenty":-43.849732,"median":-28.439666,"eighty":9.600231,"marketCap":4770441491},{"date":"2024-10-11","current":16.488334,"twenty":-43.849732,"median":-28.439666,"eighty":9.670346,"marketCap":4760561391},{"date":"2024-10-18","current":16.123321,"twenty":-43.849732,"median":-28.439666,"eighty":9.754483,"marketCap":4655173660},{"date":"2024-10-25","current":12.663801,"twenty":-43.849732,"median":-28.439666,"eighty":11.422026,"marketCap":4221427433},{"date":"2024-11-01","current":12.848249,"twenty":-43.849732,"median":-28.439666,"eighty":11.702607,"marketCap":4282912386},{"date":"2024-11-08","current":14.008329,"twenty":-43.849732,"median":-28.439666,"eighty":12.289298,"marketCap":4669620380},{"date":"2024-11-15","current":13.683118,"twenty":-43.849732,"median":-28.439666,"eighty":12.552615,"marketCap":4561212700},{"date":"2024-11-22","current":13.969498,"twenty":-43.849732,"median":-28.439666,"eighty":12.712777,"marketCap":4656676180},{"date":"2024-11-29","current":14.085991,"twenty":-43.849732,"median":-28.439666,"eighty":12.812597,"marketCap":4695508782},{"date":"2024-12-06","current":15.27034,"twenty":-43.849732,"median":-28.439666,"eighty":12.900671,"marketCap":5090306901},{"date":"2024-12-13","current":14.809221,"twenty":-43.849732,"median":-28.439666,"eighty":13.110355,"marketCap":4936594519},{"date":"2024-12-20","current":14.42091,"twenty":-43.849732,"median":-28.439666,"eighty":13.442537,"marketCap":4807152512},{"date":"2024-12-27","current":14.343247,"twenty":-43.849732,"median":-28.439666,"eighty":13.559902,"marketCap":4781264111},{"date":"2025-01-03","current":14.095699,"twenty":-43.849732,"median":-28.439666,"eighty":13.693488,"marketCap":4698744832},{"date":"2025-01-10","current":13.629725,"twenty":-43.863842,"median":-28.440211,"eighty":13.770488,"marketCap":4543414424},{"date":"2025-01-17","current":14.304416,"twenty":-43.863842,"median":-28.440211,"eighty":13.833589,"marketCap":4768319910},{"date":"2025-01-24","current":15.139285,"twenty":-43.863842,"median":-28.440211,"eighty":13.948176,"marketCap":5046620224},{"date":"2025-01-31","current":15.304318,"twenty":-43.863842,"median":-28.440211,"eighty":13.976354,"marketCap":5101633077},{"date":"2025-02-07","current":15.323733,"twenty":-43.863842,"median":-28.440211,"eighty":14.085991,"marketCap":5108105177},{"date":"2025-02-14","current":15.899471,"twenty":-43.863842,"median":-28.440211,"eighty":14.192777,"marketCap":5836218864},{"date":"2025-02-21","current":15.646958,"twenty":-43.863842,"median":-28.440211,"eighty":14.231608,"marketCap":5743528846},{"date":"2025-02-28","current":15.208382,"twenty":-43.863842,"median":-28.440211,"eighty":14.30927,"marketCap":5582540920},{"date":"2025-03-07","current":15.217242,"twenty":-43.873027,"median":-28.454574,"eighty":14.44615,"marketCap":5585793201},{"date":"2025-03-14","current":15.075481,"twenty":-43.873027,"median":-28.454574,"eighty":14.62089,"marketCap":5533756700},{"date":"2025-03-21","current":15.327994,"twenty":-43.873027,"median":-28.454574,"eighty":14.815514,"marketCap":5626446718},{"date":"2025-03-28","current":14.913262,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5474211098},{"date":"2025-04-04","current":13.498725,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4954976983},{"date":"2025-04-11","current":12.124603,"twenty":-43.863842,"median":-28.440211,"eighty":14.886883,"marketCap":4450578129},{"date":"2025-04-17","current":12.124603,"twenty":-43.863842,"median":-28.440211,"eighty":14.886883,"marketCap":4450578129},{"date":"2025-04-25","current":12.501813,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4589040559},{"date":"2025-05-02","current":14.858162,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5240562837},{"date":"2025-05-09","current":14.086734,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4968475717},{"date":"2025-05-16","current":14.68985,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5181198374},{"date":"2025-05-23","current":14.049332,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4955283614},{"date":"2025-05-30","current":14.142838,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4988263871},{"date":"2025-06-06","current":14.493487,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5111939835},{"date":"2025-06-13","current":14.39063,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5075661552},{"date":"2025-06-20","current":13.712709,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4836554689},{"date":"2025-06-27","current":13.478943,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4754104046},{"date":"2025-07-03","current":13.488294,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4757402072},{"date":"2025-07-11","current":14.24102,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":5022893141},{"date":"2025-07-18","current":13.726735,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4841501727},{"date":"2025-07-25","current":12.40362,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4374831091},{"date":"2025-08-01","current":12.549766,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4372915663},{"date":"2025-08-08","current":12.59951,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4390248851},{"date":"2025-08-15","current":13.388312,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4665103686},{"date":"2025-08-22","current":13.767316,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4797166069},{"date":"2025-08-29","current":13.705728,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4775705932},{"date":"2025-09-05","current":13.70099,"twenty":-43.891396,"median":-28.472159,"eighty":14.891062,"marketCap":4774055152},{"date":"2025-09-12","current":13.127747,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4574310798},{"date":"2025-09-19","current":13.525701,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4712976300},{"date":"2025-09-26","current":12.852969,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4478565570},{"date":"2025-10-03","current":14.809576,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":5160337623},{"date":"2025-10-10","current":14.866427,"twenty":-43.882212,"median":-28.468938,"eighty":14.901614,"marketCap":5180146981},{"date":"2025-10-17","current":14.591649,"twenty":-43.882212,"median":-28.468938,"eighty":14.926634,"marketCap":5084401753},{"date":"2025-10-24","current":14.231595,"twenty":-43.882212,"median":-28.468938,"eighty":14.926634,"marketCap":4958942489},{"date":"2025-10-31","current":15.019277,"twenty":-43.882212,"median":-28.43912,"eighty":15.006893,"marketCap":5088921627},{"date":"2025-11-07","current":15.438375,"twenty":-43.882212,"median":-28.345638,"eighty":15.018474,"marketCap":5230922685},{"date":"2025-11-14","current":15.111868,"twenty":-43.882212,"median":-28.24177,"eighty":15.075763,"marketCap":5120293954},{"date":"2025-11-21","current":13.737619,"twenty":-43.882212,"median":-28.181663,"eighty":15.075763,"marketCap":4654662578},{"date":"2025-11-28","current":14.414997,"twenty":-43.882212,"median":-28.038026,"eighty":15.075763,"marketCap":4884175916},{"date":"2025-12-05","current":14.278547,"twenty":-43.882212,"median":-27.899005,"eighty":15.075763,"marketCap":4837943013},{"date":"2025-12-12","current":14.215195,"twenty":-43.674768,"median":-27.712042,"eighty":15.075763,"marketCap":4816477737},{"date":"2025-12-19","current":13.552437,"twenty":-43.352661,"median":-27.649721,"eighty":15.075763,"marketCap":4591917925},{"date":"2025-12-26","current":13.898436,"twenty":-43.181925,"median":-27.578386,"eighty":15.075763,"marketCap":4709151356},{"date":"2026-01-02","current":13.635282,"twenty":-42.896368,"median":-27.514693,"eighty":15.075763,"marketCap":4619987901},{"date":"2026-01-09","current":14.424744,"twenty":-42.786484,"median":-27.36293,"eighty":15.075763,"marketCap":4887478266},{"date":"2026-01-16","current":15.214206,"twenty":-42.614728,"median":-26.975109,"eighty":15.077555,"marketCap":5154968630},{"date":"2026-01-23","current":16.544596,"twenty":-42.460696,"median":-26.774017,"eighty":15.108565,"marketCap":5605739430},{"date":"2026-01-30","current":16.997806,"twenty":-42.298396,"median":9.072035,"eighty":15.139285,"marketCap":5759298713},{"date":"2026-02-06","current":16.349667,"twenty":-42.121898,"median":9.212264,"eighty":15.161285,"marketCap":5539692426},{"date":"2026-02-13","current":16.222964,"twenty":-41.959732,"median":9.350441,"eighty":15.201872,"marketCap":5496761874},{"date":"2026-02-20","current":15.594318,"twenty":-41.959732,"median":9.370022,"eighty":15.220786,"marketCap":5283760288},{"date":"2026-02-27","current":21.19121,"twenty":-41.959732,"median":9.407027,"eighty":15.261496,"marketCap":5121152471},{"date":"2026-03-06","current":19.549977,"twenty":-41.959732,"median":9.422608,"eighty":15.297588,"marketCap":4724525628},{"date":"2026-03-13","current":19.060366,"twenty":-41.959732,"median":9.46156,"eighty":15.319151,"marketCap":4606204175},{"date":"2026-03-20","current":19.584457,"twenty":-41.959732,"median":9.512199,"eighty":15.336854,"marketCap":4732858125},{"date":"2026-03-27","current":20.632639,"twenty":-41.959732,"median":9.570627,"eighty":15.412902,"marketCap":4986166025},{"date":"2026-04-02","current":24.112643,"twenty":-41.959732,"median":9.593999,"eighty":15.466036,"marketCap":5827157765},{"date":"2026-04-10","current":24.02321,"twenty":-41.959732,"median":9.664113,"eighty":15.524453,"marketCap":5805544912},{"date":"2026-04-17","current":23.228627,"twenty":-41.959732,"median":9.742018,"eighty":15.606447,"marketCap":5613523023},{"date":"2026-04-24","current":23.32838,"twenty":-41.959732,"median":11.418222,"eighty":15.661134,"marketCap":5637629667},{"date":"2026-05-01","current":23.19079,"twenty":-41.959732,"median":11.622713,"eighty":15.730243,"marketCap":5604379123},{"date":"2026-05-08","current":38.634911,"twenty":-41.959732,"median":11.940489,"eighty":15.814201,"marketCap":5900323567},{"date":"2026-05-15","current":41.8654,"twenty":-41.959732,"median":12.174,"eighty":15.879905,"marketCap":6393683956},{"date":"2026-05-22","current":40.326552,"twenty":-41.959732,"median":12.331299,"eighty":15.906771,"marketCap":6158671068},{"date":"2026-05-29","current":43.589783,"twenty":-41.964268,"median":12.423564,"eighty":15.957458,"marketCap":6657031731},{"date":"2026-06-05","current":47.344136,"twenty":-41.959732,"median":12.501813,"eighty":16.013817,"marketCap":7230396507},{"date":"2026-06-12","current":49.024864,"twenty":-41.898367,"median":12.572144,"eighty":16.034853,"marketCap":7487077250},{"date":"2026-06-18","current":48.577398,"twenty":-41.824976,"median":12.578191,"eighty":16.107352,"marketCap":7418740169},{"date":"2026-06-26","current":57.657693,"twenty":-41.817921,"median":12.645689,"eighty":16.158784,"marketCap":8805482883},{"date":"2026-07-02","current":56.446259,"twenty":-41.803329,"median":12.68891,"eighty":16.20592,"marketCap":8620472738},{"date":"2026-07-10","current":58.694506,"twenty":-41.535725,"median":12.773878,"eighty":16.314234,"marketCap":8963824900},{"date":"2026-07-17","current":56.686363,"twenty":-41.52535,"median":12.829717,"eighty":16.483549,"marketCap":8657141415},{"date":"2026-07-24","current":57.810486,"twenty":-41.508406,"median":12.912967,"eighty":16.53282,"marketCap":8828817496},{"date":"2026-07-31","current":126.933087,"twenty":-41.435384,"median":12.976145,"eighty":16.764866,"marketCap":8393196498},{"date":"2026-08-07","current":122.721435,"twenty":-41.179453,"median":13.089846,"eighty":17.012426,"marketCap":8114709466},{"date":"2026-08-14","current":125.461546,"twenty":-40.97486,"median":13.175122,"eighty":18.458256,"marketCap":8295893800},{"date":"2026-08-21","current":121.833436,"twenty":-40.812598,"median":13.242761,"eighty":18.732957,"marketCap":8055992321},{"date":"2026-08-28","current":124.066119,"twenty":-40.574229,"median":13.376086,"eighty":18.818872,"marketCap":8203624000},{"date":"2026-09-04","current":118.941098,"twenty":-40.319528,"median":13.478325,"eighty":18.955657,"marketCap":7864742191},{"date":"2026-09-11","current":116.9875,"twenty":-40.029936,"median":13.488294,"eighty":19.071241,"marketCap":7735564471},{"date":"2026-09-18","current":118.509784,"twenty":-39.768257,"median":13.525701,"eighty":19.148634,"marketCap":7836222435},{"date":"2026-09-25","current":103.489918,"twenty":-39.554483,"median":13.563075,"eighty":19.39137,"marketCap":6843063864},{"date":"2026-10-02","current":102.855633,"twenty":-39.407277,"median":13.629725,"eighty":19.61204,"marketCap":6801123046},{"date":"2026-10-08","current":105.151745,"twenty":-39.176615,"median":13.65193,"eighty":20.12853,"marketCap":6952948808}],"updateTime":1791549426075},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALKS\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640151069","title":"Alkermes presents new phase 2 Vibrance-2 data for alixorexton in narcolepsy type 2 at SLEEP 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640151069","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640151069?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:01","pubTimestamp":1780570878,"startTime":"0","endTime":"0","summary":"Alkermes outlined plans to present new clinical data at the SLEEP 2026 meeting in Baltimore on June 14-17, 2026.Detailed results from the Phase 2 Vibrance-2 trial of alixorexton in narcolepsy type 2 will be presented in a June 17 oral session.The company flagged positive outcomes from Vibrance-2, positioning the program as supportive of continued late-stage development in narcolepsy.Additional presentations will cover Phase 3 trial designs for alixorexton in narcolepsy and new analyses on LUMRYZ, including real-world experience and idiopathic hypersomnia work.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via Business Wire  on June 04, 2026, and is solely res","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDLc7PWGY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640318797","title":"Mizuho Securities Reaffirms Their Buy Rating on Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640318797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640318797?lang=en_us&edition=fundamental","pubTime":"2026-06-04 06:35","pubTimestamp":1780526141,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Uy Ear reiterated a Buy rating on Alkermes today and set a price target of $53.00. Ear covers the Healthcare sector, focu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-buy-rating-on-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-buy-rating-on-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640118181","title":"Alkermes to join Goldman Sachs Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2640118181","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640118181?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:06","pubTimestamp":1780517169,"startTime":"0","endTime":"0","summary":"Alkermes will join a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026.The session is scheduled for 10:00 a.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via Business Wire  on June 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL8QsXRz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2265009873.SGD","LU2237443382.USD","LU2750360997.AUD","LU1868837300.USD","LU2237443895.HKD","BK4516","GSX","LU1868836757.USD","LU2237443549.SGD","BK4550","LU0061475181.USD","LU2471134879.HKD","LU0868494708.USD","BK4504","LU0942090050.USD","LU0106831901.USD","LU1894683264.USD","LU2237443465.HKD","BK4139","IE00BFXG1179.USD","LU2471134523.USD","LU2750360641.GBP","LU0048573561.USD","BK4585","LU0251142724.SGD","LU1894683348.USD","LU0251131958.USD","LU1791807156.HKD","LU0868494617.USD","LU1868836591.USD","LU1868836914.USD","IE0002270589.USD","BK4552","LU2237443978.SGD","LU1804176565.USD","LU1668664300.SGD","LU2237443622.USD","LU0345770308.USD","ALKS","IE00B19Z3581.USD","BK4533","LU0345770993.USD","IE00B19Z3B42.SGD","LU0742534661.SGD","LU2237438978.USD","GS","LU0096364046.USD","IE00BSNM7G36.USD","LU2471134796.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640409947","title":"Is Alkermes’ (ALKS) New LYBALVI Real-World Data Quietly Reframing Its Psychiatry Investment Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2640409947","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640409947?lang=en_us&edition=fundamental","pubTime":"2026-06-03 01:23","pubTimestamp":1780420999,"startTime":"0","endTime":"0","summary":"In May 2026, Alkermes plc reported that it had presented new clinical and real-world evidence on its psychiatry portfolio, LYBALVI and ARISTADA, alongside sleep-medicine research across major U.S. psychiatric and health economics conferences, including APA, ISPOR, and others.\nA particularly important angle is Alkermes’ focus on real-world outcomes such as adherence, relapse proxies, and acute care use, which can influence how clinicians and payers view the practical value of LYBALVI versus...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/is-alkermes-alks-new-lybalvi-real-world-data-quietly-reframi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/is-alkermes-alks-new-lybalvi-real-world-data-quietly-reframi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640960047","title":"Alkermes Chief Medical Officer Craig Hopkinson sells 9,000 shares for $375,044‬","url":"https://stock-news.laohu8.com/highlight/detail?id=2640960047","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640960047?lang=en_us&edition=fundamental","pubTime":"2026-06-02 07:27","pubTimestamp":1780356444,"startTime":"0","endTime":"0","summary":"Alkermes EVP R&D and Chief Medical Officer Craig C. Hopkinson exercised options for 5,000 ordinary shares at $19.34 on June 1.Hopkinson sold 9,000 ordinary shares at an average price of $41.67 on the same day.Directly owned ordinary shares fell to 77,389 following the transactions.Employee stock options held rose to 6,356 after the exercise.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLb446MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Alkermes Chief Medical Officer Craig Hopkinson sells 9,000 shares for $375,044‬","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639670215","title":"Alkermes VP Finance Samuel Joseph Parisi disposes of 16,217 shares for $686,807.86","url":"https://stock-news.laohu8.com/highlight/detail?id=2639670215","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639670215?lang=en_us&edition=fundamental","pubTime":"2026-05-30 06:03","pubTimestamp":1780092231,"startTime":"0","endTime":"0","summary":"Alkermes VP, Finance  Samuel Joseph Parisi sold 16,217 ordinary shares on May 29, 2026 at USD 42.36.Parisi exercised employee stock options for 16,217 ordinary shares at USD 19.34 to USD 20.03.He reported direct ownership of 7,717 ordinary shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL8xQvtn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Alkermes VP Finance Samuel Joseph Parisi disposes of 16,217 shares for $686,807.86","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639493614","title":"Needham Reiterates Buy Rating on Alkermes as Preclinical ALKS 7290 Data Support Unchanged $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2639493614","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639493614?lang=en_us&edition=fundamental","pubTime":"2026-05-29 06:45","pubTimestamp":1780008320,"startTime":"0","endTime":"0","summary":"Ami Fadia, an analyst from Needham, maintained the Buy rating on Alkermes. The associated price target remains the same with $50.00. Ami Fadia has ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/needham-reiterates-buy-rating-on-alkermes-as-preclinical-alks-7290-data-support-unchanged-50-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/needham-reiterates-buy-rating-on-alkermes-as-preclinical-alks-7290-data-support-unchanged-50-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638516920","title":"Alkermes presents Phase 2 Vibrance-1 data on alixorexton in narcolepsy type 1 at ASCP meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638516920","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638516920?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:01","pubTimestamp":1779793282,"startTime":"0","endTime":"0","summary":"Alkermes set 11 poster presentations for the ASCP annual meeting in Miami on May 26-29, 2026; results will be presented in the future.New Phase 2 Vibrance-1 posters on alixorexton in narcolepsy type 1 are slated to highlight patient-reported improvements in disease severity, fatigue, cognitive functioning.Additional posters are expected to support the strategic rationale for orexin 2 receptor agonists across sleep-wake disturbance, fatigue, cognitive deficits in neuropsychiatric disease.Real-world analyses of LYBALVI and ARISTADA are scheduled to address persistence, adherence, relapse, inpatient initiation in schizophrenia, with implications for commercial positioning.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDLbSYFKf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638251668","title":"Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638251668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638251668?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:00","pubTimestamp":1779793200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUAQDBDP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637380893","title":"Alkermes presents real-world study comparing Lybalvi versus olanzapine adherence, relapse proxies","url":"https://stock-news.laohu8.com/highlight/detail?id=2637380893","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637380893?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:01","pubTimestamp":1779361264,"startTime":"0","endTime":"0","summary":"Alkermes flagged new real-world studies on LYBALVI and ARISTADA, with results already presented at spring 2026 psychiatry and health-economics conferences.Real-world analyses comparing LYBALVI with olanzapine pointed to stronger treatment adherence and persistence, with fewer relapse-related acute-care events such as hospitalizations or emergency-room visits.A separate study in young adults showed a reduction in relapse proxies in the year following LYBALVI initiation versus the prior year.The disclosures add post-launch evidence aimed at supporting LYBALVI’s positioning in schizophrenia and bipolar I disorder, with an emphasis on outcomes tied to utilization and continuity of care.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkerm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL7dfDDz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878129","title":"Alkermes shareholders approve 2018 stock plan share increase by 5.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878129","media":"Reuters","labels":["executive","shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878129?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:11","pubTimestamp":1779307908,"startTime":"0","endTime":"0","summary":"Alkermes held its annual general meeting on May 20, 2026.Shareholders backed amendments to the 2018 Stock Option and Incentive Plan, increasing the number of ordinary shares authorized for issuance under the plan by 5,900,000.Shareholders renewed the board’s authority to allot and issue shares under Irish law.Shareholders also renewed the board’s authority to disapply statutory pre-emption rights under Irish law.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2026, and is solely responsible for the information contained ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL91yff6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635039670","title":"Alkermes Advances Phase 3 Narcolepsy Study With ALKS 2680, Adding a New Catalyst to Its Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2635039670","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635039670?lang=en_us&edition=fundamental","pubTime":"2026-05-16 00:32","pubTimestamp":1778862770,"startTime":"0","endTime":"0","summary":"Alkermes plc ($ALKS) announced an update on their ongoing clinical study. The Brilliance NT1 Study 304 is a phase 3 trial run by Alkermes, Inc. to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alkermes-advances-phase-3-narcolepsy-study-with-alks-2680-adding-a-new-catalyst-to-its-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alkermes-advances-phase-3-narcolepsy-study-with-alks-2680-adding-a-new-catalyst-to-its-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635891217","title":"Alkermes Is Maintained at Outperform by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2635891217","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635891217?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:26","pubTimestamp":1778671560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALKS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 13, 2026 07:26 ET (11:26 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635242235","title":"Sector Update: Healthcare Stocks Advance Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2635242235","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635242235?lang=en_us&edition=fundamental","pubTime":"2026-05-13 03:58","pubTimestamp":1778615885,"startTime":"0","endTime":"0","summary":"Healthcare stocks advanced late Tuesday afternoon, with the NYSE Healthcare Index and the State Street Healthcare Select Sector SPDR ETF (XLV) each rising about 2%.The iShares Biotechnology ETF (IBB) ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","BK4137","LU0345774631.USD","LABU","IE00B64QTZ34.USD","BK4532","BK4139","BK4581","IE00BFXG0V08.USD","RDY","BK4567","LU0345774391.USD","LU0154236417.USD","NVOX","BK4557","LU1093756325.SGD","WST","BK4504","IE00BKVL7J92.USD","LU0106261612.USD","LU0012050646.USD","LU0348744763.USD","IE00BYQQ9H92.USD","IE00BZ1G4Q59.USD","BK4185","NVO","BK7104","XBI","BK4588","LU0128526141.USD","NVOH","BK4121","BK4599","SNDA","BK4585","LU0029874061.USD","LU1093756168.USD","BK4596","BK4523","BK7016","BK4007","XLV","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635324406","title":"Alkermes' (NASDAQ:ALKS) Conservative Accounting Might Explain Soft Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2635324406","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635324406?lang=en_us&edition=fundamental","pubTime":"2026-05-13 02:25","pubTimestamp":1778610326,"startTime":"0","endTime":"0","summary":"Soft earnings didn't appear to concern Alkermes plc's ( NASDAQ:ALKS ) shareholders over the last week. We did some...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/alkermes-nasdaqalks-conservative-accounting-might-explain-so","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/alkermes-nasdaqalks-conservative-accounting-might-explain-so","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":[".IXIC","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107990839","title":"Stock Track | Alkermes Soars 6.37% Intraday on Positive Phase 3 Trial Results for Lumryz in Idiopathic Hypersomnia","url":"https://stock-news.laohu8.com/highlight/detail?id=1107990839","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107990839?lang=en_us&edition=fundamental","pubTime":"2026-05-13 02:19","pubTimestamp":1778609983,"startTime":"0","endTime":"0","summary":"Alkermes PLC's stock surged 6.37% during Tuesday's intraday trading session following the announcement of successful late-stage clinical trial results for its investigational drug.The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634214157","title":"Alkermes Phase 3 Trial Meets Primary Endpoint for Hypersomnia Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2634214157","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634214157?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:00","pubTimestamp":1778590808,"startTime":"0","endTime":"0","summary":"Alkermes  said Tuesday a late-stage trial evaluating its investigational Lumryz oral suspension in adults with idiopathic hypersomnia, a rare condition in which patients require excessive sleep, met all primary and key secondary endpoints.The medication demonstrated statistically significant reductions in excessive daytime sleepiness alongside improvements in patient-reported disease severity when compared to a placebo, the company said.Participants who were switched to a placebo during the withdrawal phase experienced significant symptom worsening compared to subjects who continued treatment, Alkermes said.The company plans to submit a supplemental new drug application to the US Food and Drug Administration by the end of the year, it said.Shares of the company were up 1.3% in Tuesday premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634211199","title":"Analysts Conflicted on These Healthcare Names: Cronos Group (CRON), Savara (SVRA) and Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634211199","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634211199?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:30","pubTimestamp":1778589035,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cronos Group (CRON), Savara (SVRA) and Alkermes (ALKS). Cronos Gr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-cronos-group-cron-savara-svra-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-cronos-group-cron-savara-svra-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALKS","SVRA","LABU","LU0029874061.USD","LU0128526141.USD","BK4139","BK4137","XBI","XLV","CRON","HCSG","BK4557","BK4581","BK4007","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634442218","title":"BRIEF-Alkermes Announces Positive Topline Results From Revitalyz Phase 3 Study Evaluating Lumryz","url":"https://stock-news.laohu8.com/highlight/detail?id=2634442218","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634442218?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:02","pubTimestamp":1778583730,"startTime":"0","endTime":"0","summary":"BRIEF-Alkermes Announces Positive Topline Results From Revitalyz Phase 3 Study Evaluating LumryzMay 12 (Reuters) - Alkermes Plc ALKS.O:ALKERMES ANNOUNCES POSITIVE TOPLINE RESULTS FROM REVITALYZ PHASE ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA32BKGT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634218427","title":"Alkermes says Phase 3 REVITALYZ trial shows LUMRYZ improves idiopathic hypersomnia sleepiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2634218427","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634218427?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:01","pubTimestamp":1778583712,"startTime":"0","endTime":"0","summary":"Alkermes reported positive topline results from REVITALYZ, a Phase 3 study of once-nightly LUMRYZ in adults with idiopathic hypersomnia.Trial met primary endpoint, showing meaningful improvement versus placebo in daytime sleepiness and patient-reported disease severity, with safety consistent with established LUMRYZ profile.Detailed results will be presented at a future medical meeting.Company plans to file a supplemental New Drug Application with FDA by end of 2026, though it cannot market LUMRYZ for idiopathic hypersomnia before March 1, 2028 under a prior settlement.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDLbbwPvq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":7,"totalSize":175,"code":"91000000","status":"200"}]}}